AZAANTHRACENEDIONES AS ANTITUMOR AGENTS

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1987
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
7140
Agency Tracking Number:
7140
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Po Box 325, North Haven, CT, 06473
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
DONALD H BROWNING
(203) 281-0012
Business Contact:
() -
Research Institute:
n/a
Abstract
THE OBJECTIVE OF THIS PROPOSAL IS AN INTEGRATION OF A CHEMICAL AND BIOLOGICAL APPROACH TO THE COMMERCIAL DEVELOPMENT OF A NEW HETEROCYCLIC ANTITUMOR AGENT. HUMPHREYCHEMICAL COMPANY PROPOSES TO SYNTHESIZE AND BIOLOGICALLY EVALUATE A SERIES OF AZAANTHRACENE-9,10-DIONES. THE GOAL IS THE COMMERCIALIZATION OF AN ANTITUMOR AGENT THAT LACKS THE INHERENT CARDIOTOXICITY CURRENTLY EXHIBITED BY ANTINEOPLASTIC AGENTS SUCH AS MITOXANTRONE.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government